EBIT at other companies
Other financials
Where this comes from
Calculated from 10x Genomics, Inc.’s reported figures.
Plus components not separately reported this period.
The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about 10x Genomics, Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is 10x Genomics, Inc.'s EBIT?
- 10x Genomics, Inc. (TXG) reported EBIT of -$17.05M in Q1 2026.
- How has 10x Genomics, Inc.'s EBIT changed year-over-year?
- 10x Genomics, Inc.'s EBIT increased by 56.7% year-over-year, from -$39.33M to -$17.05M.
- What is the long-term trend for 10x Genomics, Inc.'s EBIT?
- Over 4 years (2021 to 2025), 10x Genomics, Inc.'s EBIT has grown at a 3.9% compound annual growth rate (CAGR), from -$52.25M to -$60.99M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.